Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shixiu Wu

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Annals of Translational Medicine|October 21, 2022
CBX4 contributes to radioresistance by regulating autophagic activity in esophageal squamous cell carcinomaHongcheng Zhu, Hui Chen, Guangzong Chen, et al.
Aging|January 28, 2020
TPGS-1000 exhibits potent anticancer activity for hepatocellular carcinoma <i>in vitro</i> and <i>in vivo</i>Yidan Chen, Liqin Mo, Xuan Wang, et al.
British Journal of Cancer|September 22, 2020
Chemoradiotherapy with extended nodal irradiation and/or erlotinib in locally advanced oesophageal squamous cell cancer: long-term update of a randomised phase 3 trialCongying Xie, Zhao Jing, Honglei Luo, et al.
BMC Cancer|April 8, 2020
Efficacy and safety of concurrent chemoradiotherapy in ECOG 2 patients with locally advanced non-small-cell lung cancer: a subgroup analysis of a randomized phase III trialNan Bi, Lipin Liu, Jun Liang, et al.
Lancet (London, England)|August 28, 2016
Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trialLi Zhang, Yan Huang, Shaodong Hong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2021
Gemcitabine Plus Cisplatin Versus Fluorouracil Plus Cisplatin as First-Line Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: Final Overall Survival Analysis of GEM20110714 Phase III StudyShaodong Hong, Yaxiong Zhang, Gengsheng Yu, et al.
International Journal of Radiation Oncology, Biology, Physics|March 7, 2021
Involved-Field Irradiation in Definitive Chemoradiotherapy for Locoregional Esophageal Squamous Cell Carcinoma: Results From the ESO-Shanghai 1 TrialHongcheng Zhu, Eleonor Rivin Del Campo, Jinjun Ye, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
Systemic Tissue and Cellular Disruption from SARS-CoV-2 Infection revealed in COVID-19 Autopsies and Spatial Omics Tissue MapsJiwoon Park, Jonathan Foox, Tyler Hether, et al.
Cell Reports. Medicine|March 2, 2022
System-wide transcriptome damage and tissue identity loss in COVID-19 patientsJiwoon Park, Jonathan Foox, Tyler Hether, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Shotgun Transcriptome and Isothermal Profiling of SARS-CoV-2 Infection Reveals Unique Host Responses, Viral Diversification, and Drug InteractionsDaniel J Butler, Christopher Mozsary, Cem Meydan, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Annals of Translational Medicine|October 21, 2022
CBX4 contributes to radioresistance by regulating autophagic activity in esophageal squamous cell carcinomaHongcheng Zhu, Hui Chen, Guangzong Chen, et al.
Aging|January 28, 2020
TPGS-1000 exhibits potent anticancer activity for hepatocellular carcinoma <i>in vitro</i> and <i>in vivo</i>Yidan Chen, Liqin Mo, Xuan Wang, et al.
British Journal of Cancer|September 22, 2020
Chemoradiotherapy with extended nodal irradiation and/or erlotinib in locally advanced oesophageal squamous cell cancer: long-term update of a randomised phase 3 trialCongying Xie, Zhao Jing, Honglei Luo, et al.
BMC Cancer|April 8, 2020
Efficacy and safety of concurrent chemoradiotherapy in ECOG 2 patients with locally advanced non-small-cell lung cancer: a subgroup analysis of a randomized phase III trialNan Bi, Lipin Liu, Jun Liang, et al.
Lancet (London, England)|August 28, 2016
Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trialLi Zhang, Yan Huang, Shaodong Hong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2021
Gemcitabine Plus Cisplatin Versus Fluorouracil Plus Cisplatin as First-Line Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: Final Overall Survival Analysis of GEM20110714 Phase III StudyShaodong Hong, Yaxiong Zhang, Gengsheng Yu, et al.
International Journal of Radiation Oncology, Biology, Physics|March 7, 2021
Involved-Field Irradiation in Definitive Chemoradiotherapy for Locoregional Esophageal Squamous Cell Carcinoma: Results From the ESO-Shanghai 1 TrialHongcheng Zhu, Eleonor Rivin Del Campo, Jinjun Ye, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
Systemic Tissue and Cellular Disruption from SARS-CoV-2 Infection revealed in COVID-19 Autopsies and Spatial Omics Tissue MapsJiwoon Park, Jonathan Foox, Tyler Hether, et al.
Cell Reports. Medicine|March 2, 2022
System-wide transcriptome damage and tissue identity loss in COVID-19 patientsJiwoon Park, Jonathan Foox, Tyler Hether, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Shotgun Transcriptome and Isothermal Profiling of SARS-CoV-2 Infection Reveals Unique Host Responses, Viral Diversification, and Drug InteractionsDaniel J Butler, Christopher Mozsary, Cem Meydan, et al.
Pageof 9